Jubilant Pharmova Limited has received confirmation from its Registrar and Share Transfer Agent, M/s Alankit Assignments Limited, regarding the completion of share dematerialization processes. The certification verifies that for the fourth quarter (January-March 2026), all securities submitted for conversion were duly verified, listed on stock exchanges, and appropriately updated in the company’s records with the relevant depositories.
Quarterly Compliance Update
Jubilant Pharmova Limited has successfully completed its mandatory reconciliation process for equity share dematerialization for the quarter ending March 31, 2026. This process ensures the systematic transition of physical share certificates into electronic format, facilitating smoother trading and record-keeping for the company’s stakeholders.
Verification and Depository Updates
The confirmation, provided by the Registrar and Share Transfer Agent, M/s Alankit Assignments Limited, certifies that all physical certificates received during the period have undergone due verification. Following this, the certificates were mutilated and cancelled. The records have been updated to reflect the relevant depository as the registered owner of the securities, ensuring full compliance with prevailing market standards for equity management.
Source: BSE
